StonvexLoading…
StonvexStonvexStonvexCore line items from COUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $202.47M | $195.70M | $757.50M | $560.60M | $366.40M |
Operating Income | Not available | $-25.30M | $-77.40M | $-45.10M | $-29.50M |
Net Income | Not available | $-20.50M | $-51.00M | $-24.20M | $-15.60M |
EPS (Diluted) | $0.09 | $-0.12 | $-0.31 | $-0.15 | $-0.10 |
Total Assets | Not available | $1.00B | $1.00B | $995.30M | $979.90M |
Total Liabilities | Not available | $368.70M | $364.30M | $355.80M | $352.90M |
Cash & Equivalents | Not available | $789.80M | $792.60M | $797.70M | $775.10M |
Free Cash Flow OCF − CapEx | Not available | $14.40M | $107.20M | $101.80M | $68.10M |
Shares Outstanding | Not available | 169.30M | 167.90M | 166.20M | 163.50M |